Anubis, a yellow Labrador

Anubis

12-year-old Labrador. Very good boy. Has T-cell lymphoma; is not defined by it. The story

Days logged

9

Weight

86.4 lb

Tumor est.

Wed, Jun 10, 2026

2:17 PM

He's doing ok. The tumor has lost density since yesterday.

Tumor firmness: firmAppetite: normalUrination: normalSleep: normalWound odor: mild

Glad to hear that Anubis is stable.

Tue, Jun 9, 2026

ChemoAsparaginase 16,000 U IM

Little response to CCNU. Break week planned next, then vinblastine; radiation oncology consult being arranged.

6:00 PM

The CCNU did not do much, so today he got asparaginase, the top drug on his panel, with a benadryl pretreat. Back up to 86.5 lbs and the tail has not stopped. Next week is a break week so we can take a trip together, and a radiation consult is being arranged. We keep going.

Weight: 86.4 lbTumor size: lymph node still enlarged, little response to CCNUMeds given: asparaginase 16,000 U IM, benadryl 75 mg SQ

Tue, Jun 2, 2026

ChemoPivot to lomustine (CCNU) 70 mg

Protocol changed based on the sensitivity panel. Mupirocin added for the wound infection.

6:00 PM

Pivot day. Off the CHOP backbone and onto CCNU (lomustine), guided by the sensitivity panel. The tumor looks a little bigger today, which is hard to type. A new ointment for the wound after the culture found a stubborn bacteria. He got extra dinner. He knows nothing is wrong with extra dinner.

Weight: 81.1 lbTumor size: appears larger todayMeds given: lomustine (CCNU) 70 mg, mupirocin 2% ointment

Mon, Jun 1, 2026

MilestoneDrug sensitivity results: CHOP resistant

CD8+ peripheral T-cell lymphoma, stage IIIa. Asparaginase 0.60, mitoxantrone 0.59, lomustine 0.55; vincristine 0.15, doxorubicin 0.13.

6:00 PM

The drug sensitivity panel is back and it explains a lot. His cancer is CD8+ peripheral T-cell lymphoma, stage IIIa, and it is largely resistant to the CHOP drugs we started with (vincristine scored 0.15 of 1.00). The best bets are asparaginase at 0.60, mitoxantrone at 0.59, and lomustine at 0.55. The plan is changing, and honestly, having a map feels better than guessing.

Stage: IIIaImmunophenotype: CD8+ peripheral T-cell

Tue, May 26, 2026

ChemoCyclophosphamide 225 mg

Partial mass reduction. Wound culture submitted; antibiotics switched to trimethoprim sulfa.

6:00 PM

Round two: cyclophosphamide. Real news: the mass is a little smaller. The open wound over it has picked up an odor though, so a culture went off and his antibiotics changed. 81.1 lbs today, he has lost some weight this week.

Weight: 81.1 lbTumor size: partial reduction in sizeWound odor: foulMeds given: cyclophosphamide 225 mg, furosemide 80 mg, trimethoprim sulfa

Wed, May 20, 2026

MilestonePARR: T-cell clonality confirmed

Monoclonal T-cell receptor gamma amplification; no B-cell amplification.

6:00 PM

Lab confirmation: it is T-cell lymphoma. The PARR test found a single monoclonal T-cell line, which is the serious kind. He remains completely unbothered and deeply invested in whether anyone is going to open the cheese drawer.

Mon, May 18, 2026

ChemoCHOP started: vincristine 0.68 mg IV

Sample submitted for flow cytometry and drug sensitivity testing.

6:00 PM

First chemo today: vincristine, the start of the CHOP protocol. He weighed in at 86.4 lbs and charmed the entire clinic. A sample also went off to the lab for drug sensitivity testing, so the treatment can be matched to his specific cancer.

Weight: 86.4 lbMeds given: vincristine 0.68 mg IV, prednisone, cefpodoxime

Fri, May 15, 2026

MilestonePathology: suspect lymphoma

Round cell tumor with aggressive features (mitotic count 94). Immunophenotyping recommended.

6:00 PM

Biopsy results: a round cell tumor, almost certainly lymphoma, and a fast growing one. Not the news we wanted. He marked the occasion by demanding dinner forty minutes early, which honestly feels like the right attitude.

Mitotic count: 94 per 2.37 mm²

Thu, May 14, 2026

Med changePrednisone started, cyclosporine stopped

Allergy medication stopped; prednisone begun ahead of chemotherapy.

Wed, May 13, 2026

BloodworkCytology confirms neoplasia

Tue, May 12, 2026

Vet visitBiopsy of the inguinal mass

Incisional biopsy collected from the ulcerated left inguinal mass, which had grown roughly fourfold despite antibiotics.

6:00 PM

The lump we hoped was a swollen lymph node got a proper biopsy today. It has grown fast over the last few weeks, about the size of a grapefruit now, with an ulcerated patch in the middle. Anubis slept through most of the visit and woke up for the treat at the end, as is tradition.

Tumor size: left inguinal mass, roughly grapefruit sized, ulcerated center

Mon, Apr 27, 2026

MilestoneFirst sign: enlarged lymph node noticed

A swelling in the left inguinal area was first noticed at home. Early cytology read it as a reactive lymph node.